These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12782252)

  • 21. The Blockade of µ1- and κ-Opioid Receptors in the Inferior Colliculus Decreases the Expression of Panic Attack-Like Behaviours Induced by Chemical Stimulation of the Dorsal Midbrain.
    Calvo F; Almada RC; da Silva JA; Medeiros P; da Silva Soares R; de Paiva YB; Roncon CM; Coimbra NC
    Neuropsychobiology; 2019; 78(4):218-228. PubMed ID: 31514182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panicolytic-like effect of µ
    Calvo F; Almada RC; Dos Anjos-Garcia T; Falconi-Sobrinho LL; Paschoalin-Maurin T; Bazaglia-de-Sousa G; Medeiros P; Silva JAD; Lobão-Soares B; Coimbra NC
    J Psychopharmacol; 2019 May; 33(5):577-588. PubMed ID: 30663473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats.
    Glass MJ; Hahn B; Joseph A; Bodnar RJ
    Brain Res; 1994 Sep; 657(1-2):310-4. PubMed ID: 7820634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of opioid receptor blockade on acetaldehyde self-administration and ERK phosphorylation in the rat nucleus accumbens.
    Peana AT; Muggironi G; Fois GR; Zinellu M; Vinci S; Acquas E
    Alcohol; 2011 Dec; 45(8):773-83. PubMed ID: 21803531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
    Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. µ
    de Freitas RL; Medeiros P; Khan AU; Coimbra NC
    Synapse; 2016 Dec; 70(12):519-530. PubMed ID: 27503688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine.
    Mann PE; Arjune D; Romero MT; Pasternak GW; Hahn EF; Bodnar RJ
    Psychopharmacology (Berl); 1988; 94(3):336-41. PubMed ID: 2895939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
    Osaki MY; Castellan-Baldan L; Calvo F; Carvalho AD; Felippotti TT; de Oliveira R; Ubiali WA; Paschoalin-Maurin T; Elias-Filho DH; Motta V; da Silva LA; Coimbra NC
    Brain Res; 2003 Dec; 992(2):179-92. PubMed ID: 14625057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone and morphine alter the discrimination and plasma levels of ethanol.
    Kosten TA; Haile CN; Jatlow P
    Behav Pharmacol; 1999 Feb; 10(1):1-13. PubMed ID: 10780298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system.
    Poznanski P; Lesniak A; Korostynski M; Szklarczyk K; Lazarczyk M; Religa P; Bujalska-Zadrozny M; Sadowski B; Sacharczuk M
    Neuropharmacology; 2017 May; 118():90-101. PubMed ID: 28322978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.
    Lindholm S; Werme M; Brené S; Franck J
    Behav Brain Res; 2001 May; 120(2):137-46. PubMed ID: 11182162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats.
    Verborgh C; Meert TF
    Pain; 1999 Oct; 83(1):17-24. PubMed ID: 10506668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice.
    Chien CC; Lee YJ; Fan LW; Ho IK; Tien LT
    Toxicol Lett; 2012 Jul; 212(1):61-5. PubMed ID: 22564758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.
    Kelley AE; Bless EP; Swanson CJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1499-507. PubMed ID: 8819538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys.
    Gatch MB; Liguori A; Negus SS; Mello NK; Bergman J
    Eur J Pharmacol; 1996 Feb; 298(1):31-6. PubMed ID: 8867916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse.
    Tanda G; Di Chiara G
    Eur J Neurosci; 1998 Mar; 10(3):1179-87. PubMed ID: 9753186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning.
    Davis CM; Stevenson GW; Cañadas F; Ullrich T; Rice KC; Riley AL
    Psychopharmacology (Berl); 2009 Apr; 203(2):421-9. PubMed ID: 18594795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.